MedPath

BREPCO BIOPHARMA LIMITED

🇮🇪Ireland
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:4
Completed:0

Trial Phases

1 Phases

Phase 1:3

Drug Approvals

4

EMA:2
CIMA_AEMPS:2

Drug Approvals

Neoatricon

Authorization Status
Authorised
Approval Date
May 27, 2024
EMA

Neoatricon

Authorization Status
Authorised
Approval Date
May 27, 2024
EMA

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.